| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 01/13/2005 | CA2531111A1 Nanoparticles of polyoxyethylenated derivatives |
| 01/13/2005 | CA2530811A1 Zeolites for delivery of nitric oxide |
| 01/13/2005 | CA2530783A1 Drop pills prepared from excipients derived from natural sources |
| 01/13/2005 | CA2530591A1 Pan-kir2dl nk-receptor antibodies and their use in diagnostik and therapy |
| 01/13/2005 | CA2530272A1 Antibodies that cross-react with two or more kir2dl nk cell reporters and potentiate nk cell cytotoxicity |
| 01/13/2005 | CA2530157A1 Barrier formulation comprising a silicone based emulsion |
| 01/13/2005 | CA2530032A1 Deployable multifunctional hemostatic agent |
| 01/13/2005 | CA2516107A1 A method for production of emulsion-based microparticles |
| 01/12/2005 | EP1496095A1 Refrigerant compositions, refrigerant auxiliary compositions and uses thereof |
| 01/12/2005 | EP1496064A1 Nitrate active principle |
| 01/12/2005 | EP1495781A2 Cartridge for a device for targeted epithelial delivery of medicinal and related agents |
| 01/12/2005 | EP1495764A1 Drinking tea for treating dermatitis |
| 01/12/2005 | EP1495762A1 Therapeutic lotion for dermatitis |
| 01/12/2005 | EP1495759A1 Solid dispersion composition |
| 01/12/2005 | EP1495758A2 Formulations and methods for treatment of mucosal associated conditions with an immune response modifier |
| 01/12/2005 | EP1495120A2 Means and methods for the specific modulation of target genes in the cns and the eye and methods for their identification |
| 01/12/2005 | EP1495103A1 Targeted controlled delivery compositions activated by changes in ph or salt concentration |
| 01/12/2005 | EP1495075A2 Solid emulsions based on thermoplastic elastomers |
| 01/12/2005 | EP1495034A2 Mimics of acyl coenzyme-a comprising pantolactone and pantothenic acid derivatives, compositions thereof, and methods of cholesterol management and related uses |
| 01/12/2005 | EP1495014A2 Novel flavanoids and chalcones as chemotherapeutic, chemopreventive, and antiangiogenic agents |
| 01/12/2005 | EP1494998A2 Multiple-component solid phases containing at least one active pharmaceutical ingredient |
| 01/12/2005 | EP1494992A2 Carbocyclic and oxacarbocyclic fumaric acid oligomers |
| 01/12/2005 | EP1494756A2 Chemiluminescent treatment of acne |
| 01/12/2005 | EP1494752A1 Method of treating biological materials with translating electrical fields and electrode polarity reversal |
| 01/12/2005 | EP1494731A1 Patch stabilization of rods for treatment of cardiac muscle |
| 01/12/2005 | EP1494719A1 Injectable veterinary composition for small animals |
| 01/12/2005 | EP1494715A1 Fp receptor antagonists or pgf2 aplha antagonists for treating menorrhagia |
| 01/12/2005 | EP1494704A1 Glp-1 agonist and cardiovascular complications |
| 01/12/2005 | EP1494696A2 Treatment of lung disorder |
| 01/12/2005 | EP1494692A1 Topical pharmaceutical compositions comprising proanthocyanidins for the treatment of dermatitis |
| 01/12/2005 | EP1494690A2 Cochleates made with purified soy phosphatidylserine |
| 01/12/2005 | EP1494683A1 Method for inhibiting bone resorption with an alendronate and vitamin d formulation |
| 01/12/2005 | EP1494666A1 Orally deliverable pharmaceutical composition comprising an active compound having an aminosulfonyl group (cox-2 inhibitor), a polyethylene glycol and a free-radical scavenging antioxidant |
| 01/12/2005 | EP1494656A1 Analgesic oral composition with controlled release of an opioid |
| 01/12/2005 | EP1494655A1 Agent for producing a sensation of satiety and for weight loss |
| 01/12/2005 | EP1494654A1 Palatable chewable tablet |
| 01/12/2005 | EP1494653A1 Sustained release pharmaceutical prepartations and methods for producing the same |
| 01/12/2005 | EP1494652A1 Excipient for use in dry powder inhalation preparations |
| 01/12/2005 | EP1494651A2 Preservation of bioactive materials by freeze dried foam |
| 01/12/2005 | EP1494650A1 Pharmaceutical formulation comprising melatonin |
| 01/12/2005 | EP1494649A1 Nanoparticulate megestrol formulations |
| 01/12/2005 | EP1494648A1 Powder formulations suitable for inhalation |
| 01/12/2005 | EP1494647A1 Process for preparation of a sterile suspension of corticosteroid particles for the administration by inhalation |
| 01/12/2005 | EP1494646A1 Intravaginal matrix drug delivery devices |
| 01/12/2005 | EP1494645A2 Method of treating mucus hypersecretion |
| 01/12/2005 | EP1494644A1 Dry powder compositions |
| 01/12/2005 | EP1494634A1 Controlled delivery patch of active ingredient |
| 01/12/2005 | EP1494633A1 Adherent n,o-carboxymethylchitosan drug delivery devices for moist tissue and methods of their use |
| 01/12/2005 | EP1494630A2 Bioadhesive drug delivery system |
| 01/12/2005 | EP1494629A2 Condom |
| 01/12/2005 | EP1494542A1 Composition for modulating a physiological reaction or inducing an immune response |
| 01/12/2005 | EP1463515A4 Isoflavone composition for oral delivery |
| 01/12/2005 | EP1414435B1 Crystalline composition containing escitalopram |
| 01/12/2005 | EP1324758B1 Plga/pla-type polymer microspheres encapsulating a water-soluble substance and process thereof |
| 01/12/2005 | EP1284711B1 Process for making a blister package containing topiramate tablets |
| 01/12/2005 | EP1282407A4 Delivery mechanism for the introduction of biological substances to animals |
| 01/12/2005 | EP1242053B1 Apparatus and method for preparing microparticles using in-line solvent extraction |
| 01/12/2005 | EP1231894B1 Pharmaceutical formulations of salmeterol |
| 01/12/2005 | EP1227797B1 Solid dispersion pharmaceutical formulations |
| 01/12/2005 | EP1227734B1 Compositions comprising edible oils or fats and phytosterols and/or phytostanols dissolved therein |
| 01/12/2005 | EP1226212A4 Polymeric composition for solubilizing poorly water soluble drugs and process for the preparation thereof |
| 01/12/2005 | EP1194122B1 Methods for preparation of lipid-encapsulated therapeutic agents |
| 01/12/2005 | EP1183228B1 Esters of l-carnitine or alkanoyl l-carnitines useful as cationic lipids for the intracellular delivery of pharmacologically active compounds. |
| 01/12/2005 | EP1153624B1 Portable pain relieving device |
| 01/12/2005 | EP1152709B1 Controlled release composite |
| 01/12/2005 | EP1150686B1 Directly compressible matrix for controlled release of single daily doses of clarithromycin |
| 01/12/2005 | EP1143992B1 Therapeutic compositions containing glutathione analogs |
| 01/12/2005 | EP1117387B1 Coated medicament forms with controlled active substance release |
| 01/12/2005 | EP1089713B1 Temperature-sensitive liposomal formulation |
| 01/12/2005 | EP1087773B1 Vaginal active agent delivery procedures and formulations thereof |
| 01/12/2005 | EP1083930A4 Insulin supplemented infant formula |
| 01/12/2005 | EP1077711B1 Treatment of papilloma virus infection using a mycobacterium |
| 01/12/2005 | EP1028712B1 Solid solution beadlet |
| 01/12/2005 | EP1019026B1 Multilamellar coalescence vesicles (mlcv) containing biologically active compounds |
| 01/12/2005 | EP0998270B1 Method and device for producing a multi-layer, physiologically tolerated presentation form |
| 01/12/2005 | EP0979069B1 Method for producing orally administered, solid pharmaceutical products with controlled release of the active substance |
| 01/12/2005 | EP0977538B1 Aqueous compositions comprising a lipid and a lanolin-derived surfactant, and their use |
| 01/12/2005 | EP0973498B1 Gastrointestinal mucosa-adherent pharmaceutical composition |
| 01/12/2005 | EP0958823B1 Azelastine hydrochloride-containing percutaneous preparation having good percutaneous absorbability and reduced skin irritation |
| 01/12/2005 | EP0828499B1 Micro-encapsulated lactobacilli for medical applications |
| 01/12/2005 | EP0749304B9 Slow-release tablet containing diclofenac-na |
| 01/12/2005 | CN2669850Y Paste forming apparatus |
| 01/12/2005 | CN1564796A Stabilized compositions of aqueous reduced coenzyme Q solution |
| 01/12/2005 | CN1564695A Pharmaceutical formulation |
| 01/12/2005 | CN1564691A Interval drug release system of convulsion relieving agent |
| 01/12/2005 | CN1564689A Oral pharmaceutical products containing 17beta-estradiol-3-lower alkanoate, method of administering the same and process of preparation |
| 01/12/2005 | CN1564684A Pharmaceutical compositions |
| 01/12/2005 | CN1564681A Treatment of nail infections using NO generating compositions |
| 01/12/2005 | CN1564680A Biodegradable polymeric nanocapsules and uses thereof |
| 01/12/2005 | CN1564679A Orally administered liquid compositions comprising guaifenesin and a polyoxyalkylene block copolymer |
| 01/12/2005 | CN1564678A Lipidated glycosaminoglycan particles and their use in drug and gene delivery for diagnosis and therapy |
| 01/12/2005 | CN1564677A Aqueous dispersion comprising stable nanoparticles of a water-insoluble active and an excipient like middle chain triglycerides (MCT) |
| 01/12/2005 | CN1563368A Nano superoxide dismutase and preparation method |
| 01/12/2005 | CN1563144A Poly (2, 2-dimethylene dioxy group-1, 3 propylene glycol carbonic ester), preparaton method and application |
| 01/12/2005 | CN1563007A 9-(2-fatty ester ethoxy methyl) guanine, liposome, and preparation emthod |
| 01/12/2005 | CN1563004A Compound of quinolone carboxylic acid, preparation method and medicinal usage |
| 01/12/2005 | CN1562373A Method for preparing solid dosage forms type microsphere of alcohol soluble protein from source of plants |
| 01/12/2005 | CN1562370A Antiphlogistic and antirheumatic compound preparation |
| 01/12/2005 | CN1562369A Combination of medication for curing high blood pressure |
| 01/12/2005 | CN1562368A Oral cavity spraying agent for anticarious and preparation method |